bpc-157 human clinical trial musculoskeletal Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts BPC 157 Dosage: A Doctor's

Syringe markings and measurements U-100 insulin syringes show markings in "units" where 100 units equals 1ml

Planimetry measurements provided quantitative evidence of these clinical observations

The injection route provides higher systemic exposure and has been used for broader anti-aging goals, but it doesn't specifically target scalp follicles unless combined with scalp microinjections (intradermal mesotherapy), which requires clinical administration

Broad Gene-Expression Signal (experimental): Reported studies show changes in gene sets tied to ECM remodeling, antioxidant defenses, inflammatory signaling, and nervous-system pathways